ASHWIN GUPTA: Open Payments
NPI 1033766480 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,407 in 67 payments from 4 companies in 2025. Trend: 2023 $1,536 · 2024 $272 · 2025 $28,407
Speaker / faculty: $15,008Travel & lodging: $6,961Consulting: $4,380Food & beverage: $2,059
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 63 | $28,005 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $115 |
| ViiV Healthcare Company | 1 | $113 |
Products named: Yeztugo, Descovy, Biktarvy, XIFAXAN, RUKOBIA.
Industry payments across PA — which companies pay providers there.
